If somebody has gone through menopause and then bleeding reappears, it’s really important that the patient does not make ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...